Matos L, Vilela R, C outinho MF, Gaspar P, Alves S. Development of an antisense-mediated exon skipping approach as a therapeutic option for the ML II-causing mutation c.3503_3504delTC . 14th International Symposium SPDM. Oral Communication. March 2018. Porto, Portugal.